Sanofi (company)

Sanofi is one of the world's leading pharmaceutical corporations.

Sanofi works in more than a hundred countries. The company is headquartered in Paris.

 Overview 
The company started its work on August 20, 2004 by merging Sanofi-Synthelabo and Aventis. Since then, Sanofi-Synthelabo owns 95.47% of the share capital of Aventis.

 Structure 
Sanofi is diversified company. Sanofi's subsidiaries are  

 Sanofi Pasteur — production of vaccines;  
 Genzyme — an innovative biotechnology company;
 Chattem — production of over-the-counter drugs;
 Merial — production of veterinary drugs;
 Zentiva — production of generics.
Sanofi also has several foundations:

 Aventis Foundation — charity in the field of arts, public life, science
 Fondation Sanofi-Espoir  — charity in the field of health care in developing countries
 Patient Assistance Foundation  — charitable program for US residents who do not have the finances to buy drugs

 Management 
From October 28, 2014, the acting head of the company is Serge Weinberg.

The company's shareholders as of June 30, 2009 were:

 9.60% of shares in Total;
 8.99% at L'Oreal;
 1.37% of the company's employees;
 0.76% of treasury shares;
79.28% in free circulation.

 Activity 
The main directions of the company's work now are:

 Emerging markets;
 Diabetes;
 Vaccines;
 Health products;
 Innovative products;
 Animal health.
Sanofi-Pasteur's vaccine division provides vaccines against the following infectious diseases: cholera, diphtheria, meningococcal infection, pertussis, tetanus, tuberculosis etc.

In 2020, Sanofi together with GlaxoSmithKline began developing a vaccine against COVID-19.

 References 

Category:2000s establishments in France
Category:2004 establishments in Europe
Category:Companies based in Paris
Category:Pharmaceutical companies of Europe